International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
“While MRD testing does not eliminate the uncertainty of recurrence, Jan Pezarro explains how advanced molecular testing provides invaluable clarity for patients.
Read her commentary now in ILCN.”
Other articles about International Association for the Study of Lung Cancer on OncoDaily.